biotech · Acute Myeloid Leukemia · Sarcoma,Soft Tissue · MBRX
Moleculin Biotech
Moleculin Biotech trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Houston, USA HQ
2006 Founded
22 Employees
Public company Type
MBRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, USA
- Founded
- 2006
- Employees
- 22
- Programs
- 9
- Drugs
- 10
- Patents
- 1
Moleculin Biotech clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Moleculin Biotech programs — each row shows trial ID, program name, phase, status, and indication.
Moleculin Biotech trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Moleculin Biotech.
-
MB-108 — Phase 3
Clinical update -
MB-106 — Phase 2
Clinical update -
Placebo in combination with Cytarabine Injection — Phase 3
Clinical update -
Liposomal Annamycin — Phase 2
Clinical update -
Liposomal Annamycin (L-Annamycin) — Phase 2
Clinical update -
WP1220 — Phase 1
Clinical update -
STAT3 Inhibitor WP1066 — Phase 2
Clinical update -
MOL4239 — Phase 2
Clinical update